{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:05:39Z","timestamp":1774955139292,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Province of Salzburg","award":["F2401018-BAS"],"award-info":[{"award-number":["F2401018-BAS"]}]},{"name":"WISS 2025, Cancer Cluster Salzburg, CCSII-IOS and CCSIII-IOS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45607-w","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T17:44:47Z","timestamp":1774806287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples"],"prefix":"10.1038","volume":"16","author":[{"given":"Franz Josef","family":"Gassner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Rinnerthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Castagnaviz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Gonzalez-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Parigger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Drothler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Greil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Geisberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo F. J.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Romagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Ladisich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Sotlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Hauser-Kronberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Alinger-Scharinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Zaborsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3966-1071","authenticated-orcid":false,"given":"Simon Peter","family":"Gampenrieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"45607_CR1","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jnci\/djx273","volume":"110","author":"W Schrijver","year":"2018","unstructured":"Schrijver, W. et al. Receptor conversion in distant breast cancer metastases: A systematic review and meta-analysis. J. Natl. Cancer Inst. 110, 568\u2013580. https:\/\/doi.org\/10.1093\/jnci\/djx273 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"45607_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4021-6","volume":"18","author":"U Kjallquist","year":"2018","unstructured":"Kjallquist, U. et al. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs). BMC Cancer 18, 174. https:\/\/doi.org\/10.1186\/s12885-018-4021-6 (2018).","journal-title":"BMC Cancer"},{"key":"45607_CR3","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1158\/0008-5472.CAN-17-2310","volume":"78","author":"W Schrijver","year":"2018","unstructured":"Schrijver, W. et al. Mutation profiling of key cancer genes in primary breast cancers and their distant metastases. Cancer Res. 78, 3112\u20133121. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2310 (2018).","journal-title":"Cancer Res."},{"key":"45607_CR4","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.Cd-15-0369","volume":"5","author":"PK Brastianos","year":"2015","unstructured":"Brastianos, P. K. et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov. 5, 1164\u20131177. https:\/\/doi.org\/10.1158\/2159-8290.Cd-15-0369 (2015).","journal-title":"Cancer Discov."},{"key":"45607_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-1003-1","volume":"20","author":"MV Dieci","year":"2018","unstructured":"Dieci, M. V. et al. Immune characterization of breast cancer metastases: Prognostic implications. Breast Cancer Res. 20, 62. https:\/\/doi.org\/10.1186\/s13058-018-1003-1 (2018).","journal-title":"Breast Cancer Res."},{"key":"45607_CR6","first-page":"4655","volume":"32","author":"E Tabouret","year":"2012","unstructured":"Tabouret, E. et al. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res. 32, 4655\u20134662 (2012).","journal-title":"Anticancer Res."},{"key":"45607_CR7","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.Sabcs21-p1-21-08","author":"SP Gampenrieder","year":"2022","unstructured":"Gampenrieder, S. P. et al. Abstract P1-21-08: Brain metastases (BM) from breast cancer: Real-word data from the Austrian AGMT_MBC-registry. Cancer Res. https:\/\/doi.org\/10.1158\/1538-7445.Sabcs21-p1-21-08 (2022).","journal-title":"Cancer Res."},{"key":"45607_CR8","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1158\/1078-0432.CCR-06-2842","volume":"13","author":"M Mayer","year":"2007","unstructured":"Mayer, M. A patient perspective on brain metastases in breast cancer. Clin. Cancer Res. 13, 1623\u20131624. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2842 (2007).","journal-title":"Clin. Cancer Res."},{"key":"45607_CR9","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/bjc.2012.163","volume":"106","author":"G Frisk","year":"2012","unstructured":"Frisk, G. et al. Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden. Br. J. Cancer 106, 1850\u20131853. https:\/\/doi.org\/10.1038\/bjc.2012.163 (2012).","journal-title":"Br. J. Cancer"},{"key":"45607_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2202809","volume":"387","author":"J Cortes","year":"2022","unstructured":"Cortes, J. et al. Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. N. Engl. J. Med. 387, 217\u2013226. https:\/\/doi.org\/10.1056\/NEJMoa2202809 (2022).","journal-title":"N. Engl. J. Med."},{"key":"45607_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid, P. et al. Pembrolizumab for early triple-negative breast cancer. N. Engl. J. Med. 382, 810\u2013821. https:\/\/doi.org\/10.1056\/NEJMoa1910549 (2020).","journal-title":"N. Engl. J. Med."},{"key":"45607_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1470-2045(19)30689-8","volume":"21","author":"P Schmid","year":"2020","unstructured":"Schmid, P. et al. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): Updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 21, 44\u201359. https:\/\/doi.org\/10.1016\/S1470-2045(19)30689-8 (2020).","journal-title":"Lancet Oncol."},{"key":"45607_CR13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/oncolo\/oyac064","volume":"27","author":"I Schlam","year":"2022","unstructured":"Schlam, I. & Gatti-Mays, M. E. Immune checkpoint inhibitors in the treatment of breast cancer brain metastases. Oncologist 27, 538\u2013547. https:\/\/doi.org\/10.1093\/oncolo\/oyac064 (2022).","journal-title":"Oncologist"},{"key":"45607_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcancer.2017.10.003","volume":"52","author":"MV Dieci","year":"2018","unstructured":"Dieci, M. V. et al. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. Semin. Cancer Biol. 52, 16\u201325. https:\/\/doi.org\/10.1016\/j.semcancer.2017.10.003 (2018).","journal-title":"Semin. Cancer Biol."},{"key":"45607_CR15","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170 (2014).","journal-title":"Bioinformatics"},{"key":"45607_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"45607_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/jco.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160\u20131167. https:\/\/doi.org\/10.1200\/jco.2008.18.1370 (2009).","journal-title":"J. Clin. Oncol."},{"key":"45607_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-5849-0","volume":"20","author":"AC Picornell","year":"2019","unstructured":"Picornell, A. C. et al. Breast cancer PAM50 signature: Correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series. BMC Genomics 20, 452. https:\/\/doi.org\/10.1186\/s12864-019-5849-0 (2019).","journal-title":"BMC Genomics"},{"key":"45607_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337 (2015).","journal-title":"Nat. Methods"},{"key":"45607_CR20","unstructured":"Danzinger, S. A. A. D. A. P. T. S. Automated Deconvolution Augmentation of Profiles for Tissue Specific cells < (2019). https:\/\/CRAN.R-project.org\/package=ADAPTS"},{"key":"45607_CR21","unstructured":"joseph.szustakowski@novartis.com & DeconRNASeq Deconvolution of Heterogeneous Tissue Samples for mRNA-Seq data, (2025). https:\/\/bioconductor.org\/packages\/DeconRNASeq"},{"key":"45607_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/msb.134947","volume":"10","author":"Z Altboum","year":"2014","unstructured":"Altboum, Z. et al. Digital cell quantification identifies global immune cell dynamics during influenza infection. Mol. Syst. Biol. 10, 720. https:\/\/doi.org\/10.1002\/msb.134947 (2014).","journal-title":"Mol. Syst. Biol."},{"key":"45607_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"45607_CR24","doi-asserted-by":"crossref","unstructured":"Blighe, K. & EnhancedVolcano Publication-ready volcano plots with enhanced colouring and labeling, (2025). https:\/\/bioconductor.org\/packages\/EnhancedVolcano","DOI":"10.32614\/CRAN.package.ggvolcano"},{"key":"45607_CR25","unstructured":"Yu, G. & enrichplot Visualization of Functional Enrichment Result, (2025). https:\/\/bioconductor.org\/packages\/enrichplot"},{"key":"45607_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7. https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"45607_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118 (2012).","journal-title":"OMICS"},{"key":"45607_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"45607_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0755-1","volume":"7","author":"L Zhu","year":"2019","unstructured":"Zhu, L. et al. Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors. J. Immunother. Cancer 7, 265. https:\/\/doi.org\/10.1186\/s40425-019-0755-1 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"45607_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194895","author":"MG Noh","year":"2021","unstructured":"Noh, M. G. et al. Evolution of the tumor microenvironment toward immune-suppressive seclusion during brain metastasis of breast cancer: Implications for targeted therapy. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13194895 (2021).","journal-title":"Cancers (Basel)"},{"key":"45607_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00835","volume":"11","author":"W Fu","year":"2020","unstructured":"Fu, W. et al. Single-cell atlas reveals complexity of the immunosuppressive microenvironment of initial and recurrent glioblastoma. Front. Immunol. 11, 835. https:\/\/doi.org\/10.3389\/fimmu.2020.00835 (2020).","journal-title":"Front. Immunol."},{"key":"45607_CR32","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/neuonc\/noac136","volume":"24","author":"G Griguolo","year":"2022","unstructured":"Griguolo, G. et al. A comprehensive profiling of the immune microenvironment of breast cancer brain metastases. Neuro-oncol. 24, 2146\u20132158. https:\/\/doi.org\/10.1093\/neuonc\/noac136 (2022).","journal-title":"Neuro-oncol."},{"key":"45607_CR33","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.7150\/thno.40783","volume":"10","author":"H You","year":"2020","unstructured":"You, H., Baluszek, S. & Kaminska, B. Supportive roles of brain macrophages in CNS metastases and assessment of new approaches targeting their functions. Theranostics 10, 2949\u20132964. https:\/\/doi.org\/10.7150\/thno.40783 (2020).","journal-title":"Theranostics"},{"key":"45607_CR34","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/s41556-023-01273-y","volume":"25","author":"KT Evans","year":"2023","unstructured":"Evans, K. T. et al. Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis. Nat. Cell Biol. 25, 1848\u20131859. https:\/\/doi.org\/10.1038\/s41556-023-01273-y (2023).","journal-title":"Nat. Cell Biol."},{"key":"45607_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s43018-022-00491-x","volume":"4","author":"S Garcia-Recio","year":"2023","unstructured":"Garcia-Recio, S. et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat. Cancer. 4, 128\u2013147. https:\/\/doi.org\/10.1038\/s43018-022-00491-x (2023).","journal-title":"Nat. Cancer"},{"key":"45607_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-02001-3","volume":"13","author":"AED Van Swearingen","year":"2025","unstructured":"Van Swearingen, A. E. D. et al. Genomic and immune profiling of breast cancer brain metastases. Acta Neuropathol. Commun. 13, 99. https:\/\/doi.org\/10.1186\/s40478-025-02001-3 (2025).","journal-title":"Acta Neuropathol. Commun."},{"key":"45607_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.818693","volume":"12","author":"ED Routh","year":"2022","unstructured":"Routh, E. D. et al. Comprehensive analysis of the immunogenomics of triple-negative breast cancer brain metastases from LCCC1419. Front. Oncol. 12, 818693. https:\/\/doi.org\/10.3389\/fonc.2022.818693 (2022).","journal-title":"Front. Oncol."},{"key":"45607_CR38","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1805453","volume":"379","author":"HA Tawbi","year":"2018","unstructured":"Tawbi, H. A. et al. Combined Nivolumab and Ipilimumab in melanoma metastatic to the brain. N. Engl. J. Med. 379, 722\u2013730. https:\/\/doi.org\/10.1056\/NEJMoa1805453 (2018).","journal-title":"N. Engl. J. Med."},{"key":"45607_CR39","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","volume":"396","author":"J Cortes","year":"2020","unstructured":"Cortes, J. et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): A randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet 396, 1817\u20131828. https:\/\/doi.org\/10.1016\/S0140-6736(20)32531-9 (2020).","journal-title":"Lancet"},{"key":"45607_CR40","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.annonc.2021.05.355","volume":"32","author":"LA Emens","year":"2021","unstructured":"Emens, L. A. et al. First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis. Ann. Oncol. 32, 983\u2013993. https:\/\/doi.org\/10.1016\/j.annonc.2021.05.355 (2021).","journal-title":"Ann. Oncol."},{"key":"45607_CR41","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/s41591-023-02392-7","volume":"29","author":"PK Brastianos","year":"2023","unstructured":"Brastianos, P. K. et al. Pembrolizumab in brain metastases of diverse histologies: Phase 2 trial results. Nat. Med. 29, 1728\u20131737. https:\/\/doi.org\/10.1038\/s41591-023-02392-7 (2023).","journal-title":"Nat. Med."},{"key":"45607_CR42","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin, N. U. et al. Response assessment criteria for brain metastases: Proposal from the RANO group. Lancet Oncol. 16, e270-278. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4 (2015).","journal-title":"Lancet Oncol."},{"key":"45607_CR43","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1158\/1078-0432.Ccr-24-1161","volume":"30","author":"A Giordano","year":"2024","unstructured":"Giordano, A. et al. A phase II study of atezolizumab, pertuzumab, and high-dose trastuzumab for central nervous system metastases in patients with HER2-positive breast cancer. Clin. Cancer Res. 30, 4856\u20134865. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-1161 (2024).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45607-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:15:44Z","timestamp":1774952144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45607-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45607"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45607-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Simon P. Gampenrieder received honoraria from Roche, Daiichi Sankyo, Seagen, Novartis, BMS, AstraZeneca, Pfizer, Janssen, Gilead, Eli Lilly and MSD; travel support from Roche, Amgen, Novartis, Pfizer, Bayer, Celgene, Daiichi Sankyo, Janssen and Gilead; and research grants from Roche, Daiichi Sankyo, Novartis, Pfizer, Caris Life Sciences, Lilly, Seagen, Gilead, AstraZeneca and Stemline Therapeutics.\u00a0Christoph Schwartz received honoraria from Servier and Novocure.\u00a0All other authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the province Salzburg (IRB Number: 415-E\/2262\/4-2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All patients provided written informed consent for participation and for genetic testing or died before data entry.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"10721"}}